Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTAHO Pharmaceuticals Ltd. 〉TAH9901 ADHD Trandermal Patch

TAH9901 ADHD Trandermal Patch

TAH9901 ADHD Trandermal Patch

Once daily transdermal treatment for ADHD. (Attention Deficit Hyperactivity Disorder)

Request for Collaboration
Overview
TAH9901 comprise of a ADHD treatment proven to be safe and efficacious for over 50 years, and as a stimulant, is a first line therapy for children with ADHD. TAH 9901 offers a transdermal once daily treatment for ADHD.

Uniqueness:
• Reducing dosing frequency due to longer duration
• Improved bioavailability
• Uniform plasma levels, resulting in reduced side effect
• Possibility of terminating the drug administration by simple removal of the patch
• Improved patient compliance via non-invasive, painless and simple application
Collaboration Options
We are seeking to out-license TAH9901 to a pharmaceutical company with suitable sales and marketing in the USA.
People who like this also like
  • Lesion Detecting Method and Lesion Detecting Apparatus for Breast Image in Rotating MannerLesion Detecting Method and Lesion Detecting Apparatus for Breast Image in Rotating Manner
  • TiMAX Dental ServiceTiMAX Dental Service
  • Burixafor (TG-3000)Burixafor (TG-3000)
  • Product PipelineProduct Pipeline
  • Zelnite®Zelnite®
  • Homogeneous antibody drugs (CHO-H01, H02, H03)Homogeneous antibody drugs (CHO-H01, H02, H03)
  • Dual-targeted bifunctional anti-flu drug (CHO-S05)Dual-targeted bifunctional anti-flu drug (CHO-S05)
  • SB04SB04
  • CX-5461: RNA Polymerase I (Pol I) Inhibitor ProgramCX-5461: RNA Polymerase I (Pol I) Inhibitor Program
  • Small Molecule DrugsSmall Molecule Drugs